lymphoid cancer
Adaptive Bio Receives NY State Approval for ClonoSeq in B Cell Cancers
The regulatory approval means that the assay for minimal residual disease is available to monitor B cell blood cancers in patients in all 50 states.
New Molecular Subtypes of Diffuse Large B Cell Lymphoma Identified
An exome- and expression-based analysis of 304 DLBCL cases led to five molecular subtypes, offering insights into disease pathogenesis and treatment outcomes.
British Columbia Cancer Agency Funded $9.5M for Personalized Cancer Project
NEW YORK (GenomeWeb News) – Investigators at the BC Cancer Agency in British Columbia have reeled in an infusion of C$10 million (US$9.5 million) in funding from regional and national partners to fund an effort to use genome sequencing to personalize treatments for patients with lymphoid cancers.